mRNA-1982 clinical trials

A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)

This study is testing a new mRNA vaccine called mRNA-1982 to see how safe it is and how well it helps prevent Lyme disease in healthy adults aged 18 to 70. It compares the vaccine to a dummy injection.